NCT00380081
A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia
See it on ClinicalTrials.gov ↗82 people
70.7%
29.3%
58 womenmiddle line = equal numbers24 men
- Phase
- PHASE3
- Paid for by
- Transcept Pharmaceuticals
- Finished
- 2006-07
- Health conditions
- Insomnia
- Who could join
- Anyone
- Ages
- 18 Years – 64 Years
- Average age
- mean 45.9 years
- Age 65+
- 0%
- Weight (BMI)
- mean 27.06 kilograms/square meters
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 51.2% · Black / African American 43.9% · Hispanic / Latina 2.4% · Native Hawaiian / Pacific Islander 2.4%
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 64 Years.”
- No pregnant women
Women who were pregnant could not join.
“Females who are pregnant, breast-feeding or have a positive pregnancy test”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Females who are pregnant, breast-feeding or have a positive pregnancy test”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Females of childbearing potential must use a medically acceptable method of contraception”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Body mass index (BMI) between 18-34 kg/m\^2”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“A history of psychiatric disorder as defined by DSM-IV”
Study titles and rules are shown in their original English.